Clarification Statement By The Nigeria Center For Disease Control(NCDC)
By: Moyosore Olakanmi
June 20, 2020
The Nigeria Centre For Disease Control releases a press statement to clarify the statement made by the Commissioner of Information and Health in Cross River.
The Commissioner of Information and Health in Cross River recently in a statement, had a misinterpretation regarding the country’s COVID-19 testing strategy and effort to protect the health of Nigerians from the disease.
The NCDC is leading the expansion of testing capacity for COVID-19 in Nigeria. They leverage GeneXpert equipment currently used for diagnosis of tuberculosis as part of a national strategy to scale up COVID-19 testing published in March 2020. The expansion is in collaboration with the National Tuberculosis and Leprosy Control Program (NTBLCP) and supported by partners at US-CDC, KNCV Tuberculosis Foundation, Institute of Human Virology Nigeria (IHVN) and others.
Abia, Adamawa, Benue, Borno, Cross River, Lagos, Enugu, Kaduna, Kogi, Nasarawa, Osun, Oyo, Plateau, FCT, and Rivers are states that have been prioritized the roll-out of GeneXpert with a high level of community transmission and limited or no laboratory capacity for the diagnosis of COVID-19 at the moment.
The NCDC stated clearly that there is no plan to transport positive samples from one state to the other.
NCDC says they remain strongly committed to their mandate to protect the health of Nigerians as they believe in promptly detecting the virus and halting the spread of the virus in communities which *are* largely dependent on their ability to scale up access to testing for Nigerians.